1. Home
  2. AISP vs PMVP Comparison

AISP vs PMVP Comparison

Compare AISP & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$2.52

Market Cap

77.7M

Sector

Finance

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.41

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
PMVP
Founded
2006
2013
Country
United States
United States
Employees
63
N/A
Industry
Blank Checks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.7M
76.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AISP
PMVP
Price
$2.52
$1.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
467.9K
384.7K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$222.88
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$3.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$0.83
52 Week High
$7.20
$1.88

Technical Indicators

Market Signals
Indicator
AISP
PMVP
Relative Strength Index (RSI) 54.73 50.61
Support Level $2.07 $1.37
Resistance Level $2.82 $1.50
Average True Range (ATR) 0.15 0.05
MACD 0.02 -0.00
Stochastic Oscillator 61.36 28.12

Price Performance

Historical Comparison
AISP
PMVP

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture. Airship AI's software allows customers to view structured data both in real-time as well as to conduct searches on the structured data at a later point in time.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: